Treatment of CML in pregnant patients and patients who are breastfeeding

FDA Oncology shared on X:

An expert panel convened by FDA provides perspectives on drug development for the treatment of chronic myeloid leukemia in pregnant patients and patients who are breastfeeding – via Clinical Cancer Research.

First author – Jorge Cortes and last author- Kelly Norsworthy.”

Read further.
Source: FDA Oncology/X

Authors: Jorge E. Cortes, Elisabetta Abruzzese, Elyce H. Cardonick, Sonia Hernández-Díaz, Jamie Gutierrez, Mary S. Sardegna, Erica Torres-Chavez, Miriam Dinatale, Catherine C. Lerro, Brenda J. Gehrke, Stacy S. Shord, R. Angelo De Claro, Marc R. Theoret, Peter J. DeMaria, Kelly J. Norsworthy

Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding